Home / Health / Vitamin D Deficiency Sparks Multivitamin Recall
Vitamin D Deficiency Sparks Multivitamin Recall
14 Mar
Summary
- Chewable multivitamin recalled for low vitamin D levels.
- Product distributed to 25 states and territories nationwide.
- Recall classified as Class III due to low health risk.
A voluntary recall has been initiated for Multivitamin with Fluoride Chewable Tablets, Grape Flavor, distributed across 25 states and territories. The manufacturer, Winder Laboratories, LLC, based in Winder, Georgia, issued the recall after a U.S. Food and Drug Administration (FDA) inspection revealed subpotent levels of vitamin D in the product. This deficiency means the tablets contain less vitamin D than specified.
Two versions of the affected multivitamin are involved: one with 0.25 mg fluoride and another with 1.0 mg fluoride, both in 100-tablet bottles. The recall, identified by recall number H-0569-2026 and FDA Event ID 97884, impacts 422 cases of the 0.25 mg product and 210 cases of the 1.0 mg product. Distribution records confirm shipment to numerous states and territories including California, New York, and Puerto Rico.
Initiated on October 27, 2025, and assigned a risk classification on March 13, 2026, the recall remains ongoing with no termination date listed. The FDA categorized this as a Class III recall, its lowest risk category. This classification signifies that while the product violates FDA regulations due to the vitamin D subpotency, its use or exposure is not likely to cause adverse health consequences. Vitamin D is crucial for bone health and immune system support, as it aids calcium absorption in the body.
